Fortrea to Present at the Citi Global Healthcare Conference
Fortrea to Present at the Citi Global Healthcare Conference
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Citi Global Healthcare Conference on Wednesday, December 4, 2024 at 1:45 pm ET.
美国北卡罗来纳州达勒姆，2024年11月26日（全球新闻网络）-- Fortrea（纳斯达克：FTRE），一家领先的全球合同研究机构（CRO），今天 announced 主席兼首席执行官 Tom Pike 和首席财务官 Jill McConnell 将于2024年12月4日下午1:45（ET）在花旗全球医疗会议上做演讲。
The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available after the event.
该直播网络视频将向投资者和其他感兴趣的方人士提供，并可通过访问Fortrea投资者关系网站进行观看。活动结束后将提供网络视频重播。
About Fortrea
关于Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea（纳斯达克股票代码：FTRE）是全球领先的临床开发解决方案供应商，为生命科学行业提供服务。我们与新兴和大型生物制药、生物技术、医疗器械和诊断公司合作，推动医疗创新，加速为患者带来改变生活的疗法。Fortrea提供第I至IV期临床试验管理、临床药理学和咨询服务。Fortrea的解决方案利用了三十年的经验，涵盖了20多个治疗领域，对科学严谨充满热情，拥有独特的见解和强大的研究基地网络。我们在约100个国家工作的才华横溢且多元的团队，规模适中，能够为全球客户提供专注、灵活的解决方案。了解更多关于Fortrea如何从研发到患者端成为变革力量的信息，请访问Fortrea.com，关注我们的LinkedIn和X（之前是Twitter）页面。
Fortrea Contacts:
Fortrea联系人：
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Hima Inguva（投资者）– 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek（媒体）– 919-943-5422，media@fortrea.com
Kate Dillon（媒体）-646-818-9115，kdillon@prosek.com
